Free beta access. 50 free AI tokens each week. Optional top-ups available. See what is included
← SearchNorthwestern2023Affirmative
Opening Word document…

An innovative drug pipeline is the only defense against new superbugs---novel treatments overcome ABR

Kathy Talkington 16, Pew Charitable Trust Project Director. 12/20/16, “Tracking the Pipeline of Antibiotics in Development” http://www.pewtrusts.org/en/research-and-analysis/collections/2016/12/tracking-the-pipeline-of-antibiotics-in-development

Drug-resistant bacteria, or superbugs, present a serious and worsening threat to human health. A majority of doctors have encountered patients with infections that do not respond to available treatments, and when new drugs come to market bacteria can quickly develop resistance. According to a report from the Centers for Disease Control and Prevention, 2 million Americans acquire serious infections caused by antibiotic-resistant bacteria each year, and at least 23,000 die as a result. A sustained and robust pipeline of new antibacterial drugs and novel therapies is critical to ensure that new interventions keep pace with these evolving pathogens.

Sign in to recut, update, or save this card.